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Mechanical strength and its long-term stability of bioceramic scaffolds is still a problem to treat the
osteonecrosis of the femoral head. Considering the long-term stability of diopside (DIO) ceramic but poor
mechanical strength, we developed the DIO-based porous bioceramic composites via dilute magnesium
substituted wollastonite reinforcing and three-dimensional (3D) printing. The experimental results
showed that the secondary phase (i.e. 10% magnesium substituting calcium silicate; CSM10) could readily
improve the sintering property of the bioceramic composites (DIO/CSM10-x, x ¼ 0e30) with increasing
the CSM10 content from 0% to 30%, and the presence of the CSM10 also improved the biomimetic apatite
mineralization ability in the pore struts of the scaffolds. Furthermore, the ﬂexible strength (12.5
e30 MPa) and compressive strength (14e37 MPa) of the 3D printed porous bioceramics remarkably
increased with increasing CSM10 content, and the compressive strength of DIO/CSM10-30 showed a
limited decay (from 37 MPa to 29 MPa) in the Tris buffer solution for a long time stage (8 weeks). These
ﬁndings suggest that the new CSM10-reinforced diopside porous constructs possess excellent me-
chanical properties and can potentially be used to the clinic, especially for the treatment of osteonecrosis
of the femoral head work as a bioceramic rod.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Osteonecrosis of the femoral head (ONFH) is considered as one
of the important medical problems due to its unknown patho-
genesis, inadequate treatment, and poor biological performance of
implants. The best way to treat this degenerative disease and theenerative Medicine Research
NanoSystems Institute,
, 310058, China.




ing by Elsevier B.V. on behalf of Ke
d/4.0/).complications in the early stage is to prepare the porous implants
which can reserve the blood supply of the femoral head and can
subsequently maintain bone remodeling, and thus to control the
development of the disease [1,2]. Although the porous tantalum rod
is found partly effective to control the development, it is still a
challenge to maintain the satisﬁed biomechanical support and to
conduct bone regeneration due to its inert nature and mechanical
deﬁciency [3e5].
It has been widely investigated that integration of osteogenic
(stem) cells, growth factors or proteins with bioengineering scaf-
folds can promote vascularization and osteogenesis and is favorable
for treatment of ONFH. For instance, basic ﬁbroblast growth factor,
rhBMP-2 and mesenchymal stromal cells were integrated intoAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND
D. He et al. / Bioactive Materials 1 (2016) 85e9286biomaterial matrixes to facilitate osteogenesis in many attempt
investigations [6e8]. However, these approaches are restricted
because of the high cost, complex techniques, short half-lives of
angiogenic growth factors, and the potential safety problems
caused by the uncontrollable release behavior of growth factors
in vivo [2,9].
On the other hand, the artiﬁcial implant materials that can
provide permanent integration and the ability to stimulate the
osteogenesis and vascularization are of special signiﬁcance for the
successful reconstruction treatment in ONFH [10]. A number of
calcium phosphate (CaP) materials have historically been used for
ONFH ﬁlling repair [11,12]. However, these materials are lowly
bioactive, or may retard vascularization and osteogenesis if they
were implanted solely. A variety of studies and applications showed
that the low bioactivity of conventional CaP implants, and difﬁ-
culties in pores enlargement of sparingly soluble CaP constructs
have raised some concerns and resulted in limited use in many
bone reconstruction situations [13,14]. In fact, the ideal bio-
materials for porous constructs should have the capability to
induce rapid and adequate vascularization and osteogenesis as well
as prolonged mechanical stability.
In this context, the desired features of ONFH ﬁller should
possess: 1) good integration of materials and femoral tissues to
facilitate osteogenic fusion; 2) uniform interconnected pores and
excellent bioactivity to promote the rapid and complete osteo-
genesis; 3) slow biodegradation to provide prolonged mechanical
support; and 4) strong, non-brittle construct to easy to insert. Ca-
silicate ceramics have developed as promising biomaterials for
hard tissue regeneration [15]. It has reported that the wollastonite
ceramic can not only stimulate osteogenic cell differentiation, but
also be able to enhance proangiogenesis of endothelial cells (ECs)
[16]. Diba et al. have systematically reviewed that biological per-
formance of the Mg-containing Ca-silicate (CSM) bioceramics such
as diopside (CaMgSi2O6) [17]. Some studies have conﬁrmed that
diopside is bioactive, but very stable in vitro and in vivo [18,19]. Our
previous studies have demonstrated that the dilute Mg substituted
wollastonite (porous) ceramics have the exceptional sintering
properties and outstanding mechanical performances and, at the
same time, to stimulate osteogenesis in vivo [20e23]. Thus, it could
be hypothesized that diopside is a good choice for the porous
substrate but the CSM may act as multifunctional additive to
enhance the mechanical and biological performances of the
diopside-based bioceramics.
Three-dimensional (3D) printing is an advanced additive
manufacturing technique which facilitates in building up complex
constructs with periodic macropores and adjustable geometrical
parameters [24]. A fully interconnected macroporous structure can
mimic the external cell matrix (ECM) properties (e.g., mechanical
support, cellular activity and protein production through
biochemical and mechanical interactions), and provide a template
for cell attachment and stimulate new bone tissue formation in vivo
[25]. Therefore, we demonstrated herein the new diopside-based
porous bioceramics that were endowed with fully interconnected
macropores, adequate open porosity (>50%) and pore size
(~300 mm), and high-bioactivity pore wall favorable for rapid
osteogenesis. The diopside-based scaffolds were fabricated by
ceramic ink writing assembly, and CSM was added to reinforce its
mechanical and biological properties. It is reasonable to consider
that such new bioactive porous constructs, independent of con-
ventional growth factors, are potentially perfect for enhancing the
treatment of ONFH.2. Materials and methods
2.1. Preparation of powders
The wollastonite powders with 10% Mg-substituting-Ca (deno-
ted as CSM10) were synthesized by a conventional wet-chemical
co-precipitation method as described previously [20]. The as-
calcined CSM10 powders were ground to the particle size of
600e1500 nm. The diopside powders were synthesized by a wet-
chemical co-precipitation method and were also ground for 6 h.
2.2. Preparation of scaffolds
The powder composites of the diopside and CSM10 with
different CSM10 contents (x%) from 0 to 30 wt% were mechanically
mixed by ball milling in ethanol for 30 min, and then dried at 90 C
overnight. Then the paste of the powders for layer-by-layer printing
of the porous scaffolds was prepared by mixing 4.5 g of powders
with 4.0 g of 6.0% polyvinyl alcohol (PVA, Sigma-Aldrich) solution.
Thus, the scaffolds with 0/90 strut structure were prepared by
using our home-made 3D printing equipment [21]. After that, the
samples were dried at 80 C overnight, and then heat to 1150 C for
3 h with the heating rate of 3 C/min. The pore size of the sintered
scaffolds (denoted as DIO/CSM10-x; x¼ 0,10, 20, 30) were ~320 mm.
2.3. Microstructure characterization
In order to investigate the size distribution of particles, dynamic
light scattering (DLS, Malven Instrument 2000) was used. The
scaffolds were veriﬁed by X-ray diffractometer (XRD; Rigaku D/
max-rA) using CuKa radiation (l ¼ 1.5406 Å) at 40 kV/40 mA.
Data were collected with a step of 0.02/2q and a dwell time of 1.5 s
to identify crystalline phase of the scaffolds. The scaffold
morphology and pore structure were observed by scanning elec-
tron microscopy (SEM; JEM-6700F). The mCT analysis (SkyScan), a
powerful investigative and non-destructive testing method, was
employed to characterize the pores interconnectivity, and 2D and
3D constructs of the sintered scaffolds. The porosity of the bio-
ceramic scaffolds (n ¼ 4) was measured using the Archimedes
method in distilled water.
2.4. In vitro bioactivity assessment in SBF
The four groups of DIO/CSM10-x (x ¼ 0, 10, 20, 30) samples
(7  7  7 mm; n ¼ 4) were immersed in SBF with a ratio of 1.0 g of
scaffold to 200 mL of SBF at 37 C and the formation of CHA was
monitored on the scaffolds. After soaking for 1, 4, 7, 10, and 14 d,
1.0 mL of supernatant was extracted for inductively coupled
plasma-optical emission spectrometry (ICP-OES; Thermo) mea-
surement. An equal volume of fresh buffer was added, and the
solution was refreshed every 3 d. After 14 d, the scaffolds were
washed with absolute ethanol and observed by SEM.
2.5. Degradation and mechanical stability evaluation of the
scaffolds in vitro
For evaluation of degradation, the DIO/CSM10-x scaffolds (n¼ 16;
7 7 7mm)wereweighed (W0) and immersed in 37 C Tris buffer
with an initial pH 7.4 for 2, 4, and 8weeks, respectively, and a ratio of
1.0 g of scaffold to 200 mL of buffer was used. After the pre-set time
stage, the scaffolds were rinsedwith absolute ethanol and then dried
Fig. 2. Linear (length, width, height) shrinkage of the four different scaffolds after
sintering. *p < 0.05.
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expressed asWt/W0 100%. Themechanical strength of the as-dried
scaffolds was also determined by Instron testing machine. The
porosity of the bioceramic scaffolds (n¼ 4) was also measured using
the Archimedes method in distilled water at each time point.
2.6. Statistical analysis
The results were expressed as mean ± standard deviation
(mean ± SD). Statistical analysis was carried out using one-way
ANOVA, and a p-value of less than 0.05 (p < 0.05) was considered
statistically signiﬁcant.
3. Results and discussion
3.1. Primary characterization of the bioceramic powders and
scaffolds
A series of CSM10-reinforced diopside porous scaffolds were
prepared with adding CSM10 of 0%, 10%, 20%, and 30% in mass
percent. Fig. 1A shows the XRD patterns of the bioceramic scaffolds
for four of the compositions in this series. With increasing CSM10%
ratio from 10% to 30%, the secondary phase of wollastonite (CaSiO3;
PDF# 27-0088) became clearly detectable, suggesting an evolution
in composition from mono- to bi-phasic hybrids, and indicated the
fact that the intensity of peaks for diopside decreases signiﬁcantly.
Direct ceramic ink writing is one of 3D printing technologies
that offers unparalleled ﬂexibility in achieving controlled compo-
sition, geometric shape, and complexity over traditional
manufacturing methods [26,27]. Although the bioactive ceramic
scaffolds consisting of irregular pores were evaluated as bone im-
plants [28], the poor pore interconnectivity cannot meet theFig. 1. XRD patterns of the DIO/CSM10-x scaffolds after sinterindemands of the practical applications via conventional sacriﬁcial
template (porogen) sintering method. In contrast, introduction of
inkjet printing of porous diopside-based bioceramics must be
necessary for giving an assurance of their self-reinforcement,
because the binder-assisted printing has signiﬁcant issues about
strut densiﬁcation due to high binder in ink.
In order to conﬁrm the interconnected pore architecture of the
3D printed biphasic bioceramic constructs, the internal 2D and 3D
visualizations of the representative DIO/CSM10-30 scaffold was
characterized by mCT determination. As shown in Fig. 1BeE, the
bioceramic scaffolds had a uniform porous structure with well
regular pore morphology. The constructs retained their shape withg (A) and the 2D, 3D reconstructed structure by mCT (BeE).
Fig. 3. Fracture microstructure (SEM images) of the DIO/CSM10-x scaffolds after sintering.
Fig. 4. SEM images of the pore struts in the DIO/CSM10-x scaffolds after soaking in SBF for 14 days.
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Fig. 5. Changes in Ca, Mg and Si concentration in SBF during soaking the DIO/CSM10-x
scaffolds for 1e14 days.
Fig. 6. Bending strength of the DIO/CSM10-x scaffold samples.
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were no closed pores present in the internal porous network. This
result suggests that the CSM10-reinforced diopside scaffolds
possess fully interconnected macroporous structures, which would
be potentially favorable for ﬁbrovascularization and osteogenesis in
bone defect.3.2. Microstructure characterization of bioceramic scaffolds
The bioceramic scaffolds with ﬁlament distance of ~350 mm
were patterned by extruded the DIO/CSM10-x inks through 400-
mm nozzle. According to the quantitative analyses for the scaffold
structure parameters, it was displayed that the strut thickness
(330e355 mm), pore size (310e330 mm), and porosity (50%e56%)
slightly decreased while increasing CSM10% ratio (0e30%). Fig. 2
indicated the different degree of linear shrinkage of the scaffolds
after sintering in the three orientations with increasing the CSM10
content. These quantitative analyses suggest that, the more is the
CSM10% ratio, the higher is the linear shrinkage of the bioceramic
scaffolds during the sintering process. Generally, depending on the
initial green body density, this is typically associated with high and
anisotropic shrinkage for the 3D printed scaffolds [24,29].
Fig. 3 shows the microstructure in the fracture surface of the
DIO/CSM10-x scaffolds. It should be mentioned that there were no
signiﬁcant changes in the microstructure along the length of the
bioceramic ink ﬁlaments. So each fracture surface was, in general,
representative of the whole construct. It indicated a transgranular
type of fracture for the DIO/CSM10-x (x ¼ 0, 10, 20), but both
transgranular and intergranular types of fracture can be observed
for the DIO/CSM10-30. The SEM micrographs of these DIO/CSM10-
30 ceramic particles in pore struts show softening while beginning
to bond to each other, and thus the closed pores were also hardly
noticeable, which is thought to contribute the increased mechani-
cal strength. However, it is noticed that all of the porous DIO/
CSM10-x (x ¼ 0, 10, 20) maintained shape of particles and here the
pores were the connective open pores, which would be potentially
disadvantageous for scaffold's strength.3.3. CHA formation ability on the bioceramic scaffolds
To further determine the suitability of the DIO/CSM10-x bio-
ceramic scaffolds for the application in bone repair, their surface
reactivity was tested by immersing SBF for 14 d. Fig. 4 shows SEMFig. 7. Changes in weight of the DIO/CSM10-x scaffolds after immersion in Tris buffers
for different time periods.
Fig. 8. Changes in compressive strength and porosity of the DIO/CSM10-x scaffolds
after immersion in Tris buffer for different time periods.
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occasionally observed that some globular structures precipitate on
the surface of the DIO/CSM10-x scaffolds containing 10% CSM10,
which might be identiﬁed as the ﬁrst Ca-phosphate nuclei. How-
ever, the surface of the DIO/CSM10-20 and DIO/CSM10-30 scaffolds
was completely covered by a continuous coating layer with the
typical carbonated hydroxyapatite (CHA) morphology after im-
mersion in SBF. EDX spectra (Fig. 4, inset) for the DIO/CSM10-20
and DIO/CSM10-30 showed that the chemical composition of the
surface layer slightly differed in Ca/P ratio after 14 d of immersion
in SBF, and the Ca/P ratio (~1.54e1.58) was similar to that in
calcium-deﬁcient CHA [30]. The formation of biomimetic CHA has
been reported to be responsible for the strong bonding betweenFig. 9. SEM images of the fracture surface in the pore struts in the Dbioceramics and host bone tissue [31]. The fast deposition of apatite
layer is usually considered an indication of good bioactivity in vitro.
These results suggest the addition of CSM10 is beneﬁcial for the
bioactive behavior of diopside bioceramic scaffolds.
Fig. 5 shows the changes in ion concentrations in SBF during
immersing the porous samples. The Mg concentration was
increased with immersion time, while the Ca and Si concentration
increased quickly for the composite scaffolds but then slowly varied
for the pure diopside scaffolds. In general, the formation of bio-
mimetic CHA layer in (simulated) body ﬂuid has been reported to
be responsible for an indication of good bioactivity in vitro [32]. The
bioceramic dissolution leads to a signiﬁcant decrease in weight but
new apatite layer resulted inmechanical stability. This performance
parameter is favorable for bone tissue regeneration in the early
stage. In this regard, it is reasonable to consider that a biomimetic
CHA layer can readily deposit on the surface of the pore struts in
such composite scaffolds when immersing in SBF.3.4. Mechanical properties and degradation behavior in vitro
Biodegradable scaffolds provide the initial structure and sta-
bility for tissue formation, but degrade as the tissue forms,
providing room for matrix deposition and tissue growth [33]. To
further understand the decay in strength and especially the inﬂu-
ence of CSM10 content on that, the DIO/CSM10-x scaffolds were
kept in Tris buffer up to 8 weeks. The DIO/CSM10-30 scaffolds were
underwent one-step sintering treatment with the highest initial
bending strength (~30 MPa), while the DIO/CSM10-x (x ¼ 0, 10)
scaffolds with low initial strength (12e16 MPa) were sintered with
the same sintering schedule (Fig. 6). On the other hand, the
compressive strength and weight of bioceramic scaffolds are
affected by two different mechanisms: (i) the degradation or
dissolution effect lead to the loss of strength because of the increaseIO/CSM10-x scaffolds after immersion in Tris buffer for 8 weeks.
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mationwhich ﬁlls the pores and increases the density and strength
of the material. Therefore, the ﬁnal weight and strength will
depend on which one of these mechanisms is the dominant one.
Figs. 7 and 8 shows the changes in weight and compressive
strength as a function of immersion time. The weight of all DIO/
CSM10-x (x¼ 10e30) scaffolds reduced to 91e92%within the initial
8 weeks, but the pure diopside (i.e. DIO/CSM10-0) scaffolds
changed little and remained up to 97% after 8 weeks. However, in
comparison with the DIO/CSM10-0 scaffolds, the strength decay of
the DIO/CSM10-30 was limited, from ~37 MPa at 0 week to
~29 MPa at 8 weeks. As has been mentioned above, the slight
diopside biodissolution leads to a very limited decrease in weight
but new HA mineralization results in weight and mechanical sta-
bility for the composite scaffolds. These two performances are
favorable for bone tissue regeneration in the early stage, and in turn
the new bone ingrowth offers the added beneﬁts of structural
stability and mechanical reliability for bone defect repair [34].
Fig. 9 shows the fracture microstructure of the immersed sam-
ples in the Tris buffer after 8 weeks. It is seen that the DIO/CSM10-
30 maintained denser structure in the pore struts possibly due to
the higher initial densiﬁcation. In contrast, the DIO/CSM10-x (x¼ 0,
10, 20) scaffolds produced loose and porous structure in the pore
struts, probably due to the dissolution of the CSM phase and their
low densiﬁcation nature. Thus, the high initial densiﬁcation could
be thought to be favorable for reinforce the mechanical stability
during immersion in aqueous medium.
4. Conclusions
In summary, this investigation is demonstrated that a dilute Mg
substituted wollastonite (i.e. CSM10) reinforcing approach can be
used to modulate the mechanical and biological properties of the
diopside-based porous bioceramic by the 3D printing manufacture
and conventional pressureless sintering technique. In vitro SBF
immersion experiments revealed that the appropriate amount (e.g.
30%) of CSM10 addition showed appreciable apatite formation
ability superior to pure diopside and the highly bioactive CSM10
reinforcement substantially contributed to the structural and
strength reliability in such biomimetic aqueous medium, which is
particularly beneﬁcial for enhancing osteogenic cell activity and
bone regeneration. We believe this approach presents a promising
strategy for developing biodegradation-retarding, high-strength
bioceramic scaffolds, indicating substantial promise of bone defect
repair applicationsdfor example, in in situ load-bearing bone
regeneration and repair in ONFH condition.
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